Longeveron Inc. (LGVN) Key Metrics

NASDAQ: LGVNValuation, returns, debt and efficiency ratios over 8 years.

LGVN valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$4.4M
Enterprise value
−$1.2M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
3.7
Price / book
0.8
EV / EBITDA
—
Dividend yield
—
Beta
−0.20

LGVN key metrics, 2018–2025

Fiscal year ended December 31, 2025 · U.S. dollars

LGVN valuation Price multiples at each fiscal year-end price.

Price / sales−31.1%
7.4
2025 · hover or tap a bar for each year
2024: 10.82025: 7.4 (−31.1%)
20182025
Price / book+33.2%
1.6
2025 · hover or tap a bar for each year
2024: 1.22025: 1.6 (+33.2%)
20182025
Free cash flow yield−154.7 pts
−212.4%
2025 · hover or tap a bar for each year
2024: −57.7%2025: −212.4% (−154.7 pts)
20182025

LGVN valuation history

Fiscal year-endToday8-year median

LGVN returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

LGVN debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

LGVN cash returned to shareholders

DividendsBuybacksFree cash flow

LGVN price vs earnings per share

Share price at year-endEPS (right axis)

LGVN key metrics

2018–2025
Longeveron Inc. key metrics by fiscal year
20252024202320222021202020192018
Valuation
Market capitalization$8.9M$25.8M——————
Enterprise value$5.1M$8.0M——————
Price / sales7.410.8——————
Price / book1.61.2——————
EV / sales4.23.3——————
Earnings yield−255.3%−62.0%——————
Free cash flow yield−212.4%−57.7%——————
Dividend yield—33.6%——————
Shareholder yield (dividends + buybacks)—33.6%——————
Share price at fiscal year-end$5.06$17.30$136.00$322.00$1,207.00———
Per share
Revenue per share$0.68$1.61——————
Earnings per share−$12.92−$10.73——————
Operating cash flow per share−$10.61−$9.31——————
Free cash flow per share−$10.75−$9.98——————
Cash per share$2.65$12.92——————
Book value per share$3.23$14.70——————
Tangible book value per share$1.93$13.09——————
Dividends per share—$5.81——————
Capex per share$0.14$0.67——————
Debt per share$0.47$0.97——————
Shares outstanding1.8M1.5M——————
Change in shares outstanding+18.0%———————
Returns & profitability
Return on equity (ROE)−164.7%−111.6%−157.2%−65.0%−86.5%−116.2%−66.1%−93.0%
Return on invested capital (ROIC)−619.4%−347.0%−483.6%−316.7%−254.6%−49.7%−62.8%−180.6%
Return on assets (ROA)−126.8%−84.9%−108.4%−53.7%−65.6%−37.5%−35.3%−60.2%
Return on tangible assets−284.7%−69.0%−218.7%−75.3%−42.2%−48.4%−40.9%−69.1%
Free cash flow margin—−621.2%——−838.1%−46.6%−43.1%−252.5%
Financial health
Total debt$824,000$1.4M$2.0M$2.6M$3.1M$4.1M$4.1M—
Cash & short-term investments$4.7M$19.2M$5.4M$19.7M$35.0M$816,000$1.9M$4.0M
Net debt−$3.8M−$17.8M−$3.3M−$17.1M−$31.9M$3.3M$2.3M−$4.0M
Debt / equity0.150.070.300.130.082.120.93—
Debt / assets0.080.060.170.100.070.450.39—
Current ratio1.337.601.504.1713.060.480.952.24
Quick ratio1.337.601.504.2912.960.480.952.24
Interest coverage———-62.9—-577.6——
Working capital$1.4M$17.0M$2.0M$15.4M$32.7M−$2.0M−$115,779$2.3M
Invested capital$1.8M$4.1M$3.4M$3.5M$5.6M$5.3M$6.7M$2.8M
Tangible asset value$3.4M$19.5M$4.5M$18.1M$35.1M$410,000$3.0M$5.5M
Net current asset value$865,000$16.0M$511,000$13.4M$30.1M−$5.4M−$3.8M$457,362
Graham net-net per share$0.09$10.49——————
Capital allocation
Dividends paid—$8.7M——$451,000———
Share buybacks (net)——$174,000$304,000$451,000———
Capex / revenue20.4%41.5%42.5%70.0%100.3%4.6%0.7%9.9%
Capex / depreciation0.201.040.320.961.430.330.050.28
Stock-based compensation / revenue139.9%97.3%286.6%177.3%592.6%1.5%2.4%19.9%
R&D / revenue1,004.3%340.2%1,278.7%766.8%543.0%47.5%47.5%181.6%
SG&A / revenue1,004.9%429.3%1,718.5%750.4%838.7%52.1%52.1%148.3%
Efficiency
Days sales outstanding28.614.984.740.866.428.314.60.0
Days of inventory on hand———-85.7143.6———
Days payables outstanding240.6264.8893.4603.1569.7131.7113.3302.6
Cash conversion cycle (days)-212.0-249.9-808.7-648.0-359.7-103.5-98.6-302.6
Receivables turnover12.7624.534.318.955.5012.9224.94—
Payables turnover1.521.380.410.610.642.773.221.21
Inventory turnover————2.54———
Asset turnover0.070.130.040.030.050.570.530.20
Average receivables$94,000$97,500$164,500$136,500$237,500$435,729$225,729$0
Average payables$261,000$368,500$1.2M$1.2M$1.1M$1.4M$1.2M$1.2M
Average inventory———−$170,141$281,718———
Intangibles / total assets22.3%9.4%18.9%8.8%5.5%16.7%14.0%12.8%

Computed from LGVN's annual financial statements (latest annual report filed March 17, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

LGVN valuation and financial ratios

Longeveron earned a return on equity of −164.7% and a return on invested capital of −619.4% in fiscal 2025. It ended the year with $0.8 million of debt and $4.7 million in cash and short-term investments, a net cash position of $3.8 million.

See the LGVN income statement, the LGVN chart for price history, or the LGVN stock overview for the latest quote and news.

LGVN key metrics FAQ

What is Longeveron's return on equity?

Longeveron's return on equity (ROE) was −164.7% in fiscal 2025: net income of -$22.7 million on average shareholders' equity of $13.8 million.

What is Longeveron's ROIC?

Longeveron's return on invested capital was −619.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Longeveron have?

Longeveron had total debt of $0.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.15 and more cash than debt.

What is Longeveron's free cash flow yield?

Longeveron generated -$18.9 million of free cash flow in fiscal 2025, a free cash flow yield of −212.4% on its market value at year-end ($8.9 million).

What is Longeveron's current ratio?

Longeveron's current ratio was 1.33 at the end of fiscal 2025: current assets were 1.33 times current liabilities.

Biotechnology key metrics